Announcements Trials

Browse Landscape

Phase

Phase 2 3 Phase 4 1

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Dexamethasone 56 Metformin 50 Cyclophosphamide 47 Saline Solution 39 Cytarabine 37 Cisplatin 37 Zoledronic Acid 34 Letrozole 34 Sodium Chloride 33 Carboplatin 33 Bupivacaine 31 Bevacizumab 31 Docetaxel 30 Vincristine 29 Methotrexate 29 Fluorouracil 28 Propofol 27 Capecitabine 27 Fentanyl 26 Doxorubicin 26 Rituximab 25 Drug Therapy 25 Dexmedetomidine 25 Prednisone 23 Paclitaxel 23 Gemcitabine 22 Oxaliplatin 21 Morphine 21 Radiotherapy 19 Prednisolone 19

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Interventional × bismuth tripotassium dicitrate × Clear all

NCT04527055 2024-06-24

Bsm10

National Cheng-Kung University Hospital

Phase 4 Enrolling by invitation

Dysbiosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡